Effets indésirables de la sulfasalazine : discussion de leur mécanisme et du rôle de la composante sulfamidée
Therapie, 68 6 (2013) 369-373
Published online: 2013-12-20
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Sulfasalazine–quercetin co-amorphous systems: Sustained release behaviors and enhanced pharmacokinetics
Jia Deng, Jiangying Li, Yangwen Peng, Qian Dai, Ningbo Pang, Zhe Wang, Hailu Zhang and Xin ChenEuropean Journal of Pharmaceutics and Biopharmaceutics 220 114972 (2026)
https://doi.org/10.1016/j.ejpb.2025.114972
Safety and use of IBD therapies during pregnancy and lactation
L. G. Rabinowitz, A. Gade, T. Deyhim and J. D. FeuersteinExpert Review of Gastroenterology & Hepatology 1 (2026)
https://doi.org/10.1080/17474124.2026.2615447
Clinical outcomes of maintenance therapy with sulfasalazine compared to 5‐aminosalicylates in children with ulcerative colitis
Ishrat Mansuri, Sophia Wang, Laurie Fishman, Paul A. Rufo, Enju Liu, Christina Chan and Athos BousvarosJournal of Pediatric Gastroenterology and Nutrition 80 (6) 988 (2025)
https://doi.org/10.1002/jpn3.70041
Integrated strategy for screening direct Keap1-Nrf2 PPI inhibitors from traditional Chinese medicine: a case study of Achyranthis bidentatae Radix
Ban Chen, Shuangshuang Liu, Huiyin Xia, Xican Li, Rongxin Cai, Yingqing Zhang, Yuchen Hu and Jiangtao SuJournal of Computer-Aided Molecular Design 39 (1) (2025)
https://doi.org/10.1007/s10822-025-00662-9
Co-amorphous systems of sulfasalazine with matrine-type alkaloids: Enhanced solubility behaviors and synergistic therapeutic potential
Xin Chen, Yirui Qin, Lijun Wang, Yujing Zhu, Hailu Zhang, Wenhu Liu, Mei Zeng and Qian DaiEuropean Journal of Pharmaceutics and Biopharmaceutics 203 114475 (2024)
https://doi.org/10.1016/j.ejpb.2024.114475
Fuzi lizhong pills alter microbial community compositions and metabolite profiles in ulcerative colitis rat with spleen-kidney yang deficiency syndrome
Yin-lin Zhou, Jing Wu, Hong-liang Wang, Wu-wen Feng, Fu Peng, Ruo-qi Zhang, Hong-ling Yan, Juan Liu, Yu-zhu Tan and Cheng PengJournal of Ethnopharmacology 335 118645 (2024)
https://doi.org/10.1016/j.jep.2024.118645
Safety assessment of sulfasalazine: a pharmacovigilance study based on FAERS database
Wangyu Ye, Yuan Ding, Meng Li, Zhihua Tian, Shaoli Wang and Zhen LiuFrontiers in Pharmacology 15 (2024)
https://doi.org/10.3389/fphar.2024.1452300
Bioactive peptides derived from Radix Angelicae sinensis inhibit ferroptosis in HT22 cells through direct Keap1–Nrf2 PPI inhibition
Ban Chen, Xiaojian Ouyang, Chunfeng Cheng, Dongfeng Chen, Jiangtao Su, Yuchen Hu and Xican LiRSC Advances 13 (32) 22148 (2023)
https://doi.org/10.1039/D3RA04057G
The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions
Samantha Christine Sernoskie, Alison Jee and Jack Paul UetrechtPharmacological Reviews 73 (3) 861 (2021)
https://doi.org/10.1124/pharmrev.120.000090
Sulfasalazine
Reactions Weekly 1548 (1) 245 (2015)https://doi.org/10.1007/s40278-015-0069-0